INSIGHTS ON CELL & GENE THERAPY LOGISTICS
-
![SUS - Dolly-batch-handling-solution]( "Efficient Solutions Supporting Freezing And Storage Operations In Bulk Drug Manufacturing")
Efficient Solutions Supporting Freezing And Storage Operations In Bulk Drug ManufacturingPractical strategies for reducing handling steps, minimizing product loss risk, and improving operator efficiency in frozen drug substance cold chain operations.
-
![GettyImages-1196052154-scientist-in-lab-with-bottles]( "Nalgene Low And Ultralow Particulate Containers")
Nalgene Low And Ultralow Particulate ContainersChoose the right level of clean for bioproduction storage and transport, with options designed to help manage particulate, endotoxin, sterility and material requirements across critical workflows.
-
![Vaccine distribution-GettyImages-1306332040]( "What Will It Actually Take To Build A Resilient Global Vaccine Supply Chain?")
What Will It Actually Take To Build A Resilient Global Vaccine Supply Chain?U.S. funding cuts could leave 75 million children without routine vaccines. Five supply chain leaders explain what resilience actually requires and what's at stake if the sector fails to act.
-
![pharmasource tariffs fda]( "Tariffs, FDA Chaos, And BioSecure: How CDMOs Should Operate")
Tariffs, FDA Chaos, And BioSecure: How CDMOs Should OperateTariffs, FDA workforce cuts, and a stalled BioSecure Act are reshaping CDMO strategy. Get the full policy breakdown to stress-test your supply chain planning now.
-
![Single Use Support - manufacturing]( "Why Freezing And Storage Should Not Be Designed Independently")
Why Freezing And Storage Should Not Be Designed IndependentlyFreezing and ultra-cold storage are often planned in isolation, but treating them as a single integrated system can reveal overlooked facility design opportunities.
-
![PharmaSource_Pharma Procurement Playbook A Guide to Supplier Selection eBook]( "Pharma Procurement Playbook: A Guide To Supplier Selection")
Pharma Procurement Playbook: A Guide To Supplier SelectionStop optimizing supplier selection for cost alone. This playbook from Collaborative Sourcing's Matthew Holt and Graham Phillipson gives pharma executives a cross-functional framework for selecting CDMOs and API manufacturers that won't fail you later.
-
![PharmaSource_How CDMO Pricing Works]( "The CDMO Pricing Playbook")
The CDMO Pricing PlaybookWhy do two CDMOs with identical direct costs quote prices 2.6x apart? Learn the three-element pricing framework, capacity utilization math, and market-based strategies that explain every RFQ surprise.
-
![PharmaSource_Reshoring Pressure Meets Manufacturing Reality copy]( "Reshoring Pressure Meets Manufacturing Reality")
Reshoring Pressure Meets Manufacturing RealityU.S. pharma can't reshore what domestic capacity can't absorb. Senior leaders from Takeda, Biogen, Eli Lilly, and others reveal why tariff pressure is colliding with a sterile fill-finish shortage, workforce gaps, and ADC capacity bottlenecks.
-
![PharmaSource_Partnerships for an Uncertain World copy]( "CDMO Live Europe 2026: Partnerships For An Uncertain World")
CDMO Live Europe 2026: Partnerships For An Uncertain World112 pages of executive insight from CDMO Live Europe 2026: tariffs, geopolitics, supply resilience, AI in manufacturing, and why strategic partnerships remain aspirational for most.
-
![PharmaSource_Resilience, Risk, Relationships copy]( "Resilience, Risk, And Relationships: CDMO Live Europe 2026 Report")
Resilience, Risk, And Relationships: CDMO Live Europe 2026 ReportSenior pharma leaders from Pfizer, Bayer, BioNTech and others debunk dual sourcing myths and reveal what separates strategic CDMO partnerships from transactional ones.
